ArticleMedicina (Kaunas, Lithuania)2026
Predictive Utility of the Vedolizumab Clinical Decision Support Tool in a Real-World IBD Cohort: Differential Performance in Crohn's Disease and Ulcerative Colitis.
Andreja Ocepek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.